Ticker
HIPOLIN
Analysis
Hipolin Ltd (HIPOLIN) Stock Analysis
Hipolin Ltd investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to HIPOLIN.
Hipolin Ltd
Hipolin Ltd investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to HIPOLIN.
Stock profile
Asset type
Stock
Market cap
$2.4M
Sector
Consumer Non-Durables
Industry
Household/Personal Care
Currency
INR
Ticker listings
Hipolin Ltd may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- HIPOLIN primary listing
Latest Hipolin Ltd news
Hipolin Ltd Press Release Jun 03 2026
Newspaper publication of Audited financial results for the quarter and year ended 31st March, 2026.
Hipolin Ltd Press Release May 23 2026
Hipolin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve audited standalone and cons...
Hipolin Ltd Press Release May 12 2026
Non applicability of annual secretarial compliance report as per regulation 24A of SEBI (LODR) Reg 2015.
Hipolin Ltd Press Release Apr 10 2026
We hereby submit certificate under Regulation 74(5) of SEBI (DP) Regulation ,2018 for the Quarter ended 31st March, 2026.
Hipolin Ltd Press Release Mar 30 2026
Closure of Trading window for audited financial results for quarter and year ended 31st March, 2026
Research sections
Valuation
Review valuation context for Hipolin Ltd.
Future growth
Review future growth context for Hipolin Ltd.
Past performance
Review past performance context for Hipolin Ltd.
Financial health
Review financial health context for Hipolin Ltd.
Dividend
Review dividend context for Hipolin Ltd.
Management
Review management context for Hipolin Ltd.
Ownership
Review ownership context for Hipolin Ltd.
Other information
Review other information context for Hipolin Ltd.
Community
Review community context for Hipolin Ltd.